Murray Stewart is Director of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 191,504 shares of XFOR, which is worth approximately $116,817. The most recent transaction as insider was on Jun 10, 2024, when has been sold 45,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 192K
0% 3M change
30.72% 12M change
Total Value Held $116,817

Murray Stewart Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2024
BUY
Grant, award, or other acquisition
-
45,000 Added 19.03%
191,504 Common Stock
Aug 10 2023
SELL
Open market or private sale
$137,859 $1.06 p/Share
130,056 Reduced 47.03%
146,504 Common Stock
Aug 09 2023
BUY
Grant, award, or other acquisition
-
269,893 Added 49.39%
276,560 Common Stock
Jun 06 2022
BUY
Grant, award, or other acquisition
-
6,667 Added 50.0%
6,667 Common Stock

Also insider at

AMRN
AMARIN CORP PLCUK Healthcare
RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
MS

Murray Stewart

Director
Boston, MA

Track Institutional and Insider Activities on XFOR

Follow X4 Pharmaceuticals, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XFOR shares.

Notify only if

Insider Trading

Get notified when an X4 Pharmaceuticals, Inc insider buys or sells XFOR shares.

Notify only if

News

Receive news related to X4 Pharmaceuticals, Inc

Track Activities on XFOR